Imexpharm Corporation (HOSE:IMP)
50,100
 +1,550 (3.19%)
  At close: Oct 31, 2025
3.19% (1Y)
| Market Cap | 7.72T | 
| Revenue (ttm) | 2.45T | 
| Net Income (ttm) | 333.14B | 
| Shares Out | 154.01M | 
| EPS (ttm) | 2,163.10 | 
| PE Ratio | 23.16 | 
| Forward PE | 23.17 | 
| Dividend | 500.00 (1.03%) | 
| Ex-Dividend Date | Jun 9, 2025 | 
| Volume | 54,549 | 
| Average Volume | 42,682 | 
| Open | 48,500 | 
| Previous Close | 48,550 | 
| Day's Range | 48,000 - 50,100 | 
| 52-Week Range | 36,100 - 56,500 | 
| Beta | 0.72 | 
| RSI | 45.96 | 
| Earnings Date | Jan 16, 2026 |